A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Clinical trial NCT01482221 · COMPLETED

Trial details

NCT number: NCT01482221
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2011-12-16
Primary completion: 2013-08-26
Enrollment: 542

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.